Various studies have been conducted on adjuvant therapy for colon cancer, including the use of fluorouracil and oxaliplatin in elderly patients, the delay in chemotherapy and survival advantage in stage III colon cancer, and the use of capecitabine as adjuvant treatment. Additionally, the impact of tumor budding on prognosis and prediction in stage II colon cancer has been studied.